Counselors in Melfa, VA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Mrs. Marcia Carey, LCSW Counselor - Professional Medicare: Accepting Medicare Assignments Practice Location: 16198 Warehouse Rd, Melfa, VA 23410 Phone: 757-710-6190 |
Madison Brooke Greer Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 30273 Racetrack Road, Melfa, VA 23410 Phone: 540-298-7450 |
 Mr. James S Booker, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 16198 Warehouse Rd, Melfa, VA 23410 Phone: 757-787-9517 |
News Archive
BioSpecifics reports $0.3M net income for third quarter 2011 vs. $0.5M net loss for third quarter 2010
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
Webinar series on neuroendocrine tumours
The Canadian Oncology Societies and the Canadian Association of Medical Oncologists continue the series of webcasts on Neuroendocrine Tumours by presenting an hour-long webinar by Dr. Walter Kocha, Dr. Amil Shah, and Dr. Peter Metrakos. This webinar is part two of a three-part series and will cover the subjects of Surgery, Cardiology, Radiology & Principals of Medical Management in Treatment.
Southampton researchers investigates influence of mechanical forces on cellular, molecular processes
University of Southampton researchers are at the forefront of research into mechanobiology, an emerging field of science combining biology and engineering, which investigates the influence of mechanical forces on cellular and molecular processes.
Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.
Clinical trial data of XP19986, XP13512 to be presented at Associated Professional Sleep Society meeting
XenoPort announced today that data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the Associated Professional Sleep Society meeting in San Antonio, Texas.
› Verified 7 days ago